Antivirus: a weekly digest of the latest COVID-19 research
On January 8th, I asked Along the way‘s science team to keep an eye on early reports A new virus that had recently emerged In China. When I dropped an article about that new virus by The Washington Post In slack, no joke, is that 2020 was off to a strong start clearly jinxing the whole year for the rest of humanity. Oops.
Jokes aside, this past
Decade, YearSix and a half months have been added to a bewildering flood of Terrible, Horrible, No Good, Very Bad News. More than half a year, and not only do we still not know when it will all end, we also see a tsunami of new cases in the United States and Record high hospitalizations.
There is so much we still do not know, but we know that it is going to keep going for a long, long time. We’ve got to pace ourselves if we are going to make it. That is why we are starting with a weekly format for this column instead of bombarding you with a daily dose of news. The hope is that we can give you some context for the big headlines and help you keep track of our collective scientific progress as we stumble our way toward the future. It’s still an experience, but it are a few things we will keep an eye on:
- Research – What we are learning about the virus itself: how it spreads and what it is in the human body.
- Development – Noteworthy news from the vaccine and the treatment of the fronts: we don’t link to every paper, but we will keep track of general progress and significant milestone is when they come.
- COVID view – It is a disease that is very Hill, finished, and destroyed lives. When looking at the huge number, we can sometimes forget that every case and death was a human being. These stories remind us that there’s more to the number.
We might also throw in a little non-coronavirus news just to remind you that there are other things going on in the world. Let’s get started.
- “All the virus and the outbreak that I have been involved with over the past four decades, I have never seen a virus in which the spectrum of seriousness so intense. This disease goes from nothing to death! So that really surprised me,” Anthony Fauci Said in an interview in The New York Times This week. For context, some of the virus Fauci is facing include HIV, Ebola, and Zika. (Jennifer Senior / The New York Times)
- What scientists are learning about how long Covid-19 immunity remains: If you want a deep dive into the current state of immunity of six months of research in the pandemic, our colleagues in the Vox You covered. There’s still a lot to learn, but there are also a lot of progress. (Brian Resnick and Umair Irfan / Vox)
- Education provide a glimpse into the utility of the Covid-19 vaccine from the Oxford-AstraZeneca and CanSino: A top-COVID-19 candidate vaccine produced a strong immune response and Not Production of severe side effects, according to a The study published in the medical journal The Lancet. Focusing on the study of a vaccine candidate made by Oxford University and Astra-Zeneca and involved nearly 1,000 patients. A and The study, published in the also The LancetFound that a vaccine developed by the Chinese company CanSino Biologics developed an immune response but was not as effective in people over 65 years of age. Both drugs will now have to complete Phase three cases And be tested on hundreds, if not thousands, more people. (Matthew Herper, damian Garde, and Helen Branswell / Stat)
- Some vaccine makers say they plan to profit by Coronavirus vaccine: Executives from pharmaceutical companies, testified before Congress on Tuesday and four of them on the hopes were that the world has a vaccine by late 2020 or early 2021. Two, AstraZeneca and Johnson & Johnson, said that they will produce the vaccine at a price of. One and two, modern medical and Pfizer did not. (Catherine J. Wu / The New York Times)
- Related news: On Wednesday, Pfizer and the German company BioNTech has announced that they jointly receive $1.95 billion From the US government for the development of 600 million doses of a vaccine. They join other companies who already have received commitments of federal funding. Moderna is getting $483 million, Johnson and Johnson Getting $456 millionAnd AstraZeneca Getting $1 billion.
- Notes of caution — While most executives put a rosy time line before Congress, other experts are more skeptical. Fauci Told The New York Times That families were not likely to see a vaccine until next year. “I think it’s going to be sometime in 2021. I don’t know whether that’s going to be the first quarter of 2021, the first half is difficult to say that,” Fauci said.
Immunology experts Has also been Careful, and similar other drugs executives. “I think that when people tell the public that there is going to be a vaccine by the end of 2020, he is a serious loss to the public,” Merck CEO Kenneth Frazier said In an interview hosted by the Harvard Business School last week. “I think that in the end of the day, we don’t want to rush the vaccine before we do is hard science.”
- Vaccine development Cheat Sheet — Here’s a rundown of May’s four major different vaccine development strategies in the works. (Nicole Wetsman / Way)
Want to help researchers find a vaccine? The National Institutes of Health (NIH) Create a new network Called COVID-19 of the Prevention Trials Network (COVPN) that will help connect volunteers with some of the large clinical trials that need to test the ability of coronavirus vaccine.
“Each phase 3 clinical trials that COVPN will will need thousands of volunteers” NIH Director Francis Collins said in a statement. “Community engagement, especially with communities most vulnerable to COVID-19 intense the results will be critical to the success of this research effort.”
If you want to volunteerYou’ll be asked to complete a short survey of personal questions, including where you live. If you are a good candidate for one of many studies going on across the country, a researcher will reach out to you and you more information about the study. You can then decide whether you want to attend.
Lopez drives to his fourth stop of the day, a body in the back, a cigarette in her hand. He is reflecting on the virus and how calls to take bodies started coming suddenly, one after another. They have their work personally. “Maybe my family members, it could be a friend of mine.”
Shannon Najmabadi and Miguel Gutierrez junior. Report to The Texas Tribune On what it is like to be a “last responders” in the Rio Grande Valley, where deaths and case numbers remain high.
The maximum number
To the maximum 15,762,392 people in the world who have tested positive, may your road to recovery be smooth.
Family and friends 640,278 people who have died around the world — 145,556 in their us — your loved ones are not forgotten.
Stay safe, everyone.
STAY TUNED WITH US FOR MORE INTERESTING ARTICLES ONLY ON MYTECHYBLOGS.COM